Compare Koninklijke Philips NV (PHG) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Visa Inc — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while Visa Inc trades at $353.07 (market cap $676.68B). The key difference: Visa Inc is far larger — about 26.1× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| PHG | V | |
|---|---|---|
Market Cap | $25.89B | $676.68B |
Sector | Health | Financials |
52-Week High | $32.91 | $365.14 |
52-Week Low | $25.02 | $295.52 |
Enterprise Value | $32.18B | $687.27B |
Dividend Yield | 3.81% | 0.75% |
Volume | — | 10,431,336 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
Visa (V) trades at $353.42, down 1.98% on the day, but maintains a bullish technical trend with strong analyst support. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $3.31 exceeding the $3.10 estimate. Revenue growth remains steady, reaching $40 billion in 2025, while profitability metrics like a 51.68% net income margin highlight operational efficiency. Recent news highlights Visa's push into AI-driven commerce and stablecoin partnerships, positioning it for future payment innovations.
The outlook for Visa is positive, driven by consistent earnings outperformance, high analyst buy ratings (85%), and a consensus price target of $396.70 implying ~12% upside. Key risks include competitive pressures from fintech and regulatory scrutiny, but the company's strong cash flow and market dominance provide a solid foundation for long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
